Yoshihiro Honda

Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer

Yukihiro Toi, Shunichi Sugawara, Jun Sugisaka et al. · JAMA Oncology · 2018 · 366 citations · Full text

Life Sciences, Immunology, Oncology +17

Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab

Yukihiro Toi, Shunichi Sugawara, Yosuke Kawashima et al. · The Oncologist · 2018 · 294 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Efficient, complementary binding of nucleic acid bases to diaminotriazine-functionalized monolayers on water

Kazue Kurihara, Kaori Ohto, Yoshihiro Honda et al. · Journal of the American Chemical Society · 1991 · 132 citations

Pharmacy, Biophysics, Molecular Recognition +14

Type I Interferon Induces Inhibitory 16-kD CCAAT/ Enhancer Binding Protein (C/EBP)β, Repressing the HIV-1 Long Terminal Repeat in Macrophages: Pulmonary Tuberculosis Alters C/EBP Expression, Enhancing HIV-1 Replication

Yoshihiro Honda, Linda Rogers, Koh Nakata et al. · The Journal of Experimental Medicine · 1998 · 124 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Differentiation of Monocytes to Macrophages Switches the <i>Mycobacterium tuberculosis</i> Effect on HIV-1 Replication from Stimulation to Inhibition: Modulation of Interferon Response and CCAAT/Enhancer Binding Protein β Expression

Michael D. Weiden, Naohiko Tanaka, Yaming Qiao et al. · The Journal of Immunology · 2000 · 106 citations · Full text

Life Sciences, Immunology, Molecular Biology +16